Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

Overview of attention for article published in Frontiers in endocrinology, July 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,897 followers.

New Research: Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects: Thyroid cancer (TC) is the most common endocrine malignancy. TC is classified as… https://t.co/Y3NBvJ6xKt #Endoc

08 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.